Learn more about whether Bausch + Lomb Corporation or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.
After years of decreasing amputations in the United States, rates of non-traumatic lower extremity amputations due to diabetes and related conditions are rising, and Oklahoma is among the states with ...